HRMY · Harmony Biosciences Holdings, Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-05-14 | Sabater Juan A. |
Director |
Award↑
Filing footnotes — Stock Option (Direct)
The stock option shall vest in full on the earlier to occur of (i) May 14, 2027 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. |
Stock Option
|
21,872 |
| 2026-05-14 | Philip Ron M |
Director |
Award↑
Filing footnotes — Stock Option (Direct)
The stock option shall vest in full on the earlier to occur of (i) May 14, 2027 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. |
Stock Option
|
21,872 |
| 2026-05-14 | Szyper Linda M |
Director |
Award↑
Filing footnotes — Stock Option (Direct)
The stock option shall vest in full on the earlier to occur of (i) May 14, 2027 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. |
Stock Option
|
21,872 |
| 2026-05-14 | Germano Geno J |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2026-05-14 | Sender Gary |
Director |
Award↑
Filing footnotes — Stock Option (Direct)
The stock option shall vest in full on the earlier to occur of (i) May 14, 2027 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. |
Stock Option
|
21,872 |
| 2026-05-14 | Germano Geno J |
Director |
Award↑
Filing footnotes — Stock Option (Direct)
The stock option shall vest in 36 equal monthly installments beginning on June 14, 2026. |
Stock Option
|
21,231 |
| 2026-05-14 | Graf R. Mark |
Director |
Award↑
Filing footnotes — Stock Option (Direct)
The stock option shall vest in full on the earlier to occur of (i) May 14, 2027 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. |
Stock Option
|
21,872 |
| 2026-05-01 | Budur Kumar |
CHIEF MEDICAL OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date. |
Common Stock
|
8,882 |
| 2026-05-01 | Budur Kumar |
CHIEF MEDICAL OFFICER |
Convert↑
Filing footnotes — Common Stock (Direct)
The reporting person's previous Form 4 filed on January 26, 2026 inadvertently misstated the number of shares of common stock and derivatives beneficially owned following the transactions reported therein, and that the number has been corrected in the current filing. |
Common Stock
|
18,750 |
| 2026-05-01 | Budur Kumar |
CHIEF MEDICAL OFFICER |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
The award of restricted stock units was previously granted on May 1, 2024 and shall vest in four equal annual installments beginning on May 1, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. The reporting person's previous Form 4 filed on January 26, 2026 inadvertently misstated the number of shares of common stock and derivatives beneficially owned following the transactions reported therein, and that the number has been corrected in the current filing. |
Restricted Stock Units
|
18,750 |
| 2026-04-14 | Reicin Glenn |
CHIEF FINANCIAL OFFICER |
Award↑
Filing footnotes — Stock Option (Direct)
The stock option vests with respect to 25% of the underlying shares on April 14, 2027, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date. |
Stock Option
|
164,309 |
| 2026-04-14 | Reicin Glenn |
CHIEF FINANCIAL OFFICER |
Other↑
|
No Securities Owned
|
0 |
| 2026-04-07 | Zaeske Adam H. |
CHIEF COMMERCIAL OFFICER |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
The restricted stock units shall vest in four equal annual installments beginning on April 7, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. |
Restricted Stock Units
|
7,500 |
| 2026-04-07 | Zaeske Adam H. |
CHIEF COMMERCIAL OFFICER |
Convert↑
|
Common Stock
|
7,500 |
| 2026-04-07 | Zaeske Adam H. |
CHIEF COMMERCIAL OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date |
Common Stock
|
3,173 |
| 2026-04-02 | Ignelzi Troy A. |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2026-04-02 | Ignelzi Troy A. |
Director |
Award↑
Filing footnotes — Stock Option (Direct)
The stock option shall vest in 36 equal monthly installments beginning on May 2, 2026. |
Stock Option
|
17,710 |
| 2026-04-02 | Anastasiou Peter |
Director |
Award↑
Filing footnotes — Stock Option (Direct)
The stock option vests with respect to 25% of the underlying shares on April 2, 2027, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date. |
Stock Option
|
212,241 |
| 2026-01-26 | Kapadia Sandip |
CHIEF FINANCIAL OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.57 to $37.70. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reporting person's previous Form 4 filed on January 26, 2026 inadvertently misstated the number of shares of common stock beneficially owned following the transactions reported therein, and that the number has been corrected in the current filing. |
Common Stock
|
3,746 |
| 2026-01-25 | Budur Kumar |
CHIEF MEDICAL OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date. |
Common Stock
|
1,372 |
| 2026-01-25 | Serafin Andrew |
CHIEF STRATEGY OFFICER |
Convert↑
|
Common Stock
|
2,600 |
| 2026-01-25 | Kapadia Sandip |
CHIEF FINANCIAL OFFICER |
Convert↑
|
Common Stock
|
4,725 |
| 2026-01-25 | Budur Kumar |
CHIEF MEDICAL OFFICER |
Convert↑
|
Common Stock
|
2,662 |
| 2026-01-25 | Dayno Jeffrey M. |
Director, PRESIDENT, CEO |
Tax↓
Filing footnotes — Common Stock (Direct)
Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date. |
Common Stock
|
5,654 |
| 2026-01-25 | Budur Kumar |
CHIEF MEDICAL OFFICER |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. |
Restricted Stock Units
|
2,662 |
| 2026-01-25 | Dayno Jeffrey M. |
Director, PRESIDENT, CEO |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. |
Restricted Stock Units
|
13,000 |
| 2026-01-25 | Serafin Andrew |
CHIEF STRATEGY OFFICER |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. |
Restricted Stock Units
|
2,600 |
| 2026-01-25 | Kapadia Sandip |
CHIEF FINANCIAL OFFICER |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. |
Restricted Stock Units
|
4,725 |
| 2026-01-25 | Dayno Jeffrey M. |
Director, PRESIDENT, CEO |
Convert↑
|
Common Stock
|
13,000 |
| 2026-01-25 | Kapadia Sandip |
CHIEF FINANCIAL OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date. |
Common Stock
|
2,553 |
| 2026-01-25 | Serafin Andrew |
CHIEF STRATEGY OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date. |
Common Stock
|
1,126 |
| 2026-01-24 | Serafin Andrew |
CHIEF STRATEGY OFFICER |
Convert↑
|
Common Stock
|
2,500 |
| 2026-01-24 | Dayno Jeffrey M. |
Director, PRESIDENT, CEO |
Convert↑
|
Common Stock
|
10,500 |
| 2026-01-24 | Serafin Andrew |
CHIEF STRATEGY OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date. |
Common Stock
|
1,116 |
| 2026-01-24 | Budur Kumar |
CHIEF MEDICAL OFFICER |
Convert↑
|
Common Stock
|
2,188 |
| 2026-01-24 | Dayno Jeffrey M. |
Director, PRESIDENT, CEO |
Tax↓
Filing footnotes — Common Stock (Direct)
Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date. |
Common Stock
|
4,785 |
| 2026-01-24 | Serafin Andrew |
CHIEF STRATEGY OFFICER |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. |
Restricted Stock Units
|
2,500 |
| 2026-01-24 | Dayno Jeffrey M. |
Director, PRESIDENT, CEO |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. |
Restricted Stock Units
|
10,500 |
| 2026-01-24 | Kapadia Sandip |
CHIEF FINANCIAL OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date. |
Common Stock
|
2,239 |
| 2026-01-24 | Kapadia Sandip |
CHIEF FINANCIAL OFFICER |
Convert↑
|
Common Stock
|
3,813 |
| 2026-01-24 | Budur Kumar |
CHIEF MEDICAL OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date. |
Common Stock
|
1,153 |
| 2026-01-24 | Budur Kumar |
CHIEF MEDICAL OFFICER |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. |
Restricted Stock Units
|
2,188 |
| 2026-01-24 | Kapadia Sandip |
CHIEF FINANCIAL OFFICER |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. |
Restricted Stock Units
|
3,813 |
| 2026-01-22 | Budur Kumar |
CHIEF MEDICAL OFFICER |
Award↑
Filing footnotes — Stock Option (Direct)
The stock option vests with respect to 25% of the underlying shares on January 22, 2027, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date. |
Stock Option
|
42,600 |
| 2026-01-22 | Dayno Jeffrey M. |
Director, PRESIDENT, CEO |
Award↑
Filing footnotes — Stock Option (Direct)
The stock option vests with respect to 25% of the underlying shares on January 22, 2027, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date. |
Stock Option
|
184,600 |
| 2026-01-22 | Kapadia Sandip |
CHIEF FINANCIAL OFFICER |
Award↑
Filing footnotes — Stock Option (Direct)
The stock option vests with respect to 25% of the underlying shares on January 22, 2027, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date. |
Stock Option
|
42,600 |
| 2026-01-22 | Serafin Andrew |
CHIEF STRATEGY OFFICER |
Award↑
Filing footnotes — Stock Option (Direct)
The stock option vests with respect to 25% of the underlying shares on January 22, 2027, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date. |
Stock Option
|
42,600 |
| 2026-01-22 | Kapadia Sandip |
CHIEF FINANCIAL OFFICER |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. |
Restricted Stock Units
|
12,200 |
| 2026-01-22 | Zaeske Adam H. |
CHIEF COMMERCIAL OFFICER |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. |
Restricted Stock Units
|
16,200 |
| 2026-01-22 | Dayno Jeffrey M. |
Director, PRESIDENT, CEO |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. |
Restricted Stock Units
|
52,900 |